Page 256 - Bio Engineering Approaches to Cancer Diagnosis and Treatment

Index 255

ILCs. See innate lymphoid cells (ILCs) nonspecific immunotherapy
Immune assay assisted cancer diagnostics cytokines in, 104
antibody-based immunosensors, 58 immune checkpoint inhibitors, 106
antibody-based microarray radio immunotherapy
PTM and its role in cancer diagnosis, 55 clinical and preclinical studies of, 82
combination of imaging and immunodiagnostics radiotherapy, 79
urine as noninvasive body fluid, 63 In-DTPA-octeotride, 37
monoclonal antibody-based immune assays Induced pluripotent stem cells (iPSCs), 126
multiple affinity protein profiling (mapping), Induced pluripotent stem cells, in cancer therapy,
51 126
phage display technique, 50 Inflammatory protein-driven gastric cancer
proteomic microarray, 51 signature (INPROGAS), 54
serological proteome analysis, 50 Inherited genetic abnormalities, 6
polyclonal antibody-based immune assays, 45 Innate cell-based therapy
Immune checkpoint inhibitors, 106 innate lymphoid cells, 121
Immune checkpoints, blockade of, 70 innate or adaptive immunity, 123
Immune system impairment, 3 NK cells, 121
Immunoassay diagnosis technics in cancer, 6 preclinical and clinical examination of innate
Immunoconjugates and unconjugated antibody, 78 cell therapy, 123
Immunodiagnostics, urine as noninvasive body Innate lymphoid cells (ILCs), 121
fluid, 63 Innate or adaptive immunity, 123
Immunogenic cell death (ICD), 72 INPROGAS. See inflammatory protein-driven
Immunoglobulin G (IgG), 91 gastric cancer signature (INPROGAS)
Immunomodulatory therapies, 103 Integrin, 37
Immunosensors, antibody-based, 58 Interdigital transducers (IDTs), 220
Immunosuppressive factors, 1 Interferons (IFNs), 106
Immunotherapy, 3 Interleukins, 105
antibody based targeted therapy Internal energy, 18
clinical examinations, 79 Internal reflection fluorescence microscopy
immunoconjugates and unconjugated (TIRFM), 226
antibody, 78 Intracorporeal lithotripsy, 191
mechanism of, 75 Intravenous injection, 48
whole antibody or antibody fragments, 77 In vitro detection of undifferentiated tumor cell, 4
antibody-drug conjugate In vivo detection of micro tumors, 4
antigens, 90 IPSCs. See Induced pluripotent stem cells
antobodies, 91 (iPSCs)
drugs, 93 3G molecules. See f (3G) molecules
linkers and conjugates, 92
cancer L
adoptive cell therapy, 72 Laser-assisted cancer treatment, 151
blockade of immune checkpoints, 70 cross-section absorption of graphene oxide
oncolytic viral therapy, 72 minimization of lateral thermal diffusion
tumor infiltrating lymphocyte, 74 and scattering, 149
cancer vaccine obtaining cross-section absorption of GO,
biomaterials in delivery and targeting, 101 149
DNA/mRNA vaccines, 99 near-infrared-triggered anticancer drug delivery
production, 96 photothermal-guided drug release
tumor cell vaccines, 100 (PT-NIRSRS), 145
viral vaccines, 100 two-photon conversion guided drug release
chemo immunotherapy (TP-NIRSRS), 148
chemotherapy, 84 upconverting nanoparticles guided drug
clinical examination of, 87 release (UP-NIRSRS), 148
mechanisms of, 87